BRIEF

on INVENTIVA (EPA:IVA)

Inventiva Releases First Quarter 2024 Financial Results and Business Updates

Stock price chart of INVENTIVA  (EPA:IVA) showing fluctuations.

Inventiva revealed its cash position as of March 31, 2024, with €11 million in cash, €0.1 million in short-term deposits, and €19.1 million in long-term deposits. In December 2023, these amounts were respectively 26.9 million, 0.01 million and 9 million euros.

The company consumed 29.4 million euros in operational activities in the first quarter of 2024, compared to 20.4 million for the same period in 2023. Operational financing reached 23.7 million euros thanks to an EIB loan . Inventiva expects to be able to finance its activities until the beginning of the third quarter of 2024.

Clinically, phase III of their NATiV3 trial continues without modification, with patient recruitment restarted in 15 countries. The first visit of the last patient is planned for the first half of 2024.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all INVENTIVA news